Indications
Treatment of metastatic and early breast cancer and metastatic gastric cancer (MGC)
Composition
- Active substance
- trastuzumab
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Tuznue
- Active substance
- trastuzumab
- ATC code
- L01XC03
- Therapeutic area
- Stomach Neoplasms, Breast Neoplasms
- Marketing authorisation holder
- Prestige Biopharma Belgium
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/005066